1

Møller Centre, Cambridge UK 20th April 2016

© 2016 Captum Capital Limited

A One-day Conference:

2

Introduction

Do you evaluate early stage technology to decide if it should be commercialised? If you do, this one-day conference is for you. Too often, commercialisation decisions are made on superficial or subjective evidence, potentially leading to failure of the new venture. At the conference, expert speakers will describe the techniques and tools used to evaluate technology, at an introductory to intermediate level. You probably won’t use all of these methods every time, but when you need them, you will know how.

3

Relevant questions

What is it good for?

Can it be made into a product?

Will anyone buy it?

Can it be funded?

Who else is doing it?

What are the risks?

How do we decide?

Early Stage Technology Proof of Concept Established

4

Evaluation Decision Making

License to existing company

Spin-out (License to new company)

New Technology

Commercially Viable ?

Yes

Not now

5

Program 09:00 Registration & coffee

09:30 Introduction and welcome

09:35 Health economics Dr. Stuart Hendry, HecoAnalytics

10:15 Project risks Doug Oldfield, Palisade Europe

11:00 Coffee break

11:30 Patent due diligence Dr. Gareth Williams, Marks & Clerk

12:15 Competitor intelligence Bruce Chin, FULD+

13:00 Lunch

14:00 Financial valuation Dr. Michael Brand, Captum

14:45 Decision making Dr. Chris Brand, Birkbeck, University of London

15:30 Tea break

16:00 Panel Discussion: Increasing the probability of technology success

17:00 Networking reception

18:30 Conference ends

6

Health Economics

Dr. Stuart Hendry CEO, HecoAnalytics Partner, Alacritica

• Do the economic benefits outweigh the economic costs?

• Will US third party payers recognise

the benefit?

• Will the new technology be approved

by NICE?

7

Project Risks

Doug Oldfield Business Development Manager, Palisade Europe

• What are the project risks? • Risk as probability

• Monte Carlo simulation of risk

8

Patent Due Diligence

Dr. Gareth Williams Partner, Marks & Clerk

• Is the technology fully protected? • Does it infringe existing patents?

• Is there freedom to operate in the

technology space?

9

Competitive Analysis

Bruce Chin Director of Business Development, EMEA, Fuld + Company

• What is the existing competition? • Who else is developing this

technology?

• Who has the potential to compete?

10

Financial Valuation

Dr. Michael Brand Director, Captum Capital

• How to value technology and adjust for risk

• Different people view value differently

• Will the technology interest investors?

11

Decision Making

Dr. Chris Brand Lecturer, Birkbeck University of London School of Psychological Science

• The role of uncertainty on decision

making

• Common behavioural biases

• Strategies for improving decision

making

12

Conference Registration

Registration Fees Early Registration Standard Registration

Academic £300 £350

Commercial £400 £450

Student £150 £200

Registration includes all conference materials, lunch, refreshments and the reception. 20% VAT will be added to all registration fees. Advanced registration and payment in full prior to the conference is required. Early registration ends on 6th April

13

Venue

Møller Centre Churchill College Storey’s Way Cambridge CB3 0DE www.mollercentre.co.uk T: +44 (0)1223 465500

Directions Accommodation: There is a wide range of hotel and other accommodation available in Cambridge www.trivago.co.uk

14

2016 Conference Series

27 - 28 June Sensors for Cancer Diagnosis Cambridge MA, USA

21 - 22 September Innovation in Environmental Monitoring

York, UK

12 - 13 October Sensors in Medicine 2016 London, UK

29 – 30 November Sensors in Food and Agriculture 2016 Cambridge, UK

15

Contact

Captum Capital Limited Cumberland House 35 Park Row Nottingham NG1 6EE United Kingdom t: +44 (0) 115 988 6154 e: info@captum.com

www.captum.com